IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
Stock Information for IDEAYA Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.